The loss of Irs-2 expression in β-cells has been linked to type 2 diabetes in humans: microarray comparison revealed that Irs-2 is significantly reduced in islets of patients with type 2 diabetes, as compared with controls [8]. This evidence concerns the gene IRS2 and type 2 diabetes mellitus.